Under the terms of the agreement, IsoSciences will be the exclusive provider to Aldrich for their stable isotope products listed in the agreement. These products include deuterated, 13C and 15N labeled vitamins, steroids, and other bioactive compounds used in metabolic research. These stable isotope products will be an addition to the extensive list of unlabeled bioactive compounds provided by Sigma-Aldrich.
C Tan, Isotec Stable Isotope’s R&D manager, said: “A new partnership with IsoSciences will allow Sigma-Aldrich to provide new stable isotope product lines to support our customers’ research. This collaboration offers a new range of labeled bioactive compounds for our ever expanding customer base.”
Scott Landvatter, CEO of IsoSciences, said: “Our partnership with Sigma-Aldrich will allow us the widest possible distribution of our unique stable isotope labeled compounds to scientists worldwide.”